Status:
TERMINATED
Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients
Lead Sponsor:
Maimonides Medical Center
Conditions:
COVID, Coronavirus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is a prospective randomized controlled, double blind clinical trial performed on laboratory confirmed COVID-19 infection admitted patients in the Shamir Medical Center. The trial will inclu...
Detailed Description
This study is a prospective randomized controlled, double blind clinical trial performed on laboratory confirmed COVID-19 infection admitted patients at MMC. The trial will include 30 patients who wil...
Eligibility Criteria
Inclusion
- Within 7 days of patient's need of oxygen supply
- Positive SARS-CoV-2 RT-PCR
- At least one risk factor for bad prognosis of COVID-19: hypertension, diabetes mellitus, ischemic heart disease, smoking, age\>50, etc.
- Respiratory insufficiency: Room Air SpO2 \<94% or PaO2/FiO2\<300mmHg
- Age\>18
- Ability to sign an informed consent
Exclusion
- Negative SARS-CoV-2 RT-PCR
- HBOT contraindication: pneumothorax, pneumomediastinum, claustrophobia, ear/sinus disease which aren't allowed in HBOT, known chronic pulmonary disease: severe emphysema or known pulmonary bullae.
- Pregnancy
- Inability to sign an informed consent
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04409886
Start Date
June 1 2020
End Date
January 31 2021
Last Update
June 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maimonides Medical Center
Brooklyn, New York, United States, 11219